CD274 and neoplasm: Similarly, the combination of 2.5 mg/kg BD0801 and 5 mg/kg anti-PD-L1 antibody also showed better tumor growth inhibition compared to both single treatments (T/C 30.6% for 2.5 mg/kg BD0801, T/C 53.2% for 5 mg/kg anti-PD-L1 antibody, T/C 15.1% for combination, Fig. 3D).